Apollo Group's Apollo Connect Programme Places a Large Bet on Expanding Access and Raising Care Standards

Apollo, the world's largest integrated healthcare provider, has announced the expansion of their one-of-a-kind connected care programme, Apollo Connect, across India. With this, Apollo aims to build India's largest connected healthcare ecosystem,...

US Outlook improves for Indian Pharma but Domestic demand under the Cloud

The Indian pharma sector has seen many ups and downs in recent years, including a drop from a Covid high last year, which added to pricing pressures in its most important market. However, some of the US market pricing pressures are easing..

Industry sees Increased Push for Ayurveda Signals Shift towards Scientifically Validated Nutraceuticals

The increased interest in holistic health and natural approaches to wellbeing is reflected in the drive for Ayurveda, herbal therapies, and nutraceuticals to overcome nutritional gaps. In India, the healthcare sector has developed significantly....

How US Business Opportunities are Propelling Growth for Indian Pharma Companies

The global pharmaceutical industry is currently undergoing a dynamic transformation, primarily driven by the surging demand for both cost-effective and high-quality drug manufacturing.

India's Success Story in Pediatric Vaccination Program should be Further Replicated in Adult Vaccination says Experts

The success story of India's paediatric vaccination programme should be replicated in the form of an adult vaccination programme, experts recommended at the 2nd edition of the India Vaccine Leaders Conclave (IVLC) in Mumbai on the theme...

Lupin Receives US FDA nod for Generic Esbriet Tablets

Drug maker Lupin said it has received approval from the US health regulator to market a generic product, used in the treatment of a lung disease, in the American market. The firm has received approval from the US Food and Drug Administration...

Cancer Vaccines Market to Exceed USD 19.12 Billion by 2029, with a 14.7% CAGR

The global cancer vaccines market was valued at USD 6.43 billion in 2021 and is expected to grow at a CAGR of 14.7% from USD 7.32 billion in 2022 to USD 19.12 billion by 2029. During the forecast period, the market is expected to grow at a ...

WHO Introduces Online Repository of Evidence-informed Decision-making Tools

The first of its kind, the WHO online repository of evidence-informed decision-making (EIDM) tools highlights WHO tools as well as external tools used by WHO to facilitate knowledge translation and partner organizations involved in the process....

India and Germany Partners to Bridge Healthcare Worker Gap

Indo-Euro Synchronisation (IES) has announced the groundbreaking event 'Upskilling Certification Linked to Nursing Employment in Germany' in order to foster collaborations between Germany and India. This event acted as a catalyst, highlighting...

Pyxis Oncology Completes its Acquisition of Clinical-stage Biopharma Company, Apexigen

Pyxis Oncology, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative antibody therapeutics for oncology, announced the successful completion of its acquisition of Apexigen, Inc. (Apexigen),...

© 2025 India Pharma Outlook. All Rights Reserved.